Dr Graham Wylie, CEO of MRN, has been an agent of change in the pharmaceutical industry for over 30 years. His career started at Pfizer, spanning clinical trial management, global technology platform development and change management and continued at PAREXEL as a Medical Director and then VP of Account Management. Since 2006, He has led MRN to be a major disruptor of the clinical trial process through innovations designed to deliver traditional clinical trials in the community. MRN is a market leading, global, decentralized trial company with offices in 5 countries and the ability to deliver trial visits in over 50 countries through healthcare professionals and digital technology. Dr Wylie continues to look for new and improved ways of running trials for the future, expanding MRN as it drives decentralized trials.